bearish
China Feihe (中国飞鹤) IPO: Thoughts on Valuation
732 Views30 Aug 2019 10:45
China Feihe, a leading infant milk formula (IMF) manufacturer in China, is planning to raise up to USD 1 billion to list in Hong Kong, two years...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (14 Sep 2019) - Budweiser APAC, ESR Cayman, Henlius, AllHome, Topsports14 Sep 2019
- ECM Weekly (7 Sep 2019) - China Merchants Comm REIT, Immunotech Bio, Bank of Guizhou, XD, Huize07 Sep 2019
- ECM Weekly (31 Aug 2019) - Megvii, Pharmaron, China Feihe, Home Credit, Prosus31 Aug 2019
- China Feihe (中国飞鹤) IPO: New Numbers, New Red Flag, and Demographic Risk05 Jul 2019
- China Feihe IPO Preview: Goat Bless Infant Formula Milk?17 Aug 2017
x